# A Clinical Pharmacology Study of MT-2990 in Seasonal Allergic Rhinitis Patients

> **NCT03570957** · PHASE1 · COMPLETED · sponsor: **Tanabe Pharma Corporation** · enrollment: 75 (actual)

## Conditions studied

- Seasonal Allergic Rhinitis

## Interventions

- **DRUG:** MT-2990
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03570957
- **Lead sponsor:** Tanabe Pharma Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-17
- **Primary completion:** 2018-12-27
- **Final completion:** 2018-12-27
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2025-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03570957

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03570957, "A Clinical Pharmacology Study of MT-2990 in Seasonal Allergic Rhinitis Patients". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT03570957. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*